tiprankstipranks
Advertisement
Advertisement
Wockhardt Submits NDA for Novel Antibiotic to U.S. FDA
PremiumCompany AnnouncementsWockhardt Submits NDA for Novel Antibiotic to U.S. FDA
7M ago
Wockhardt Limited Reports Q1 2025 Financial Results
Premium
Company Announcements
Wockhardt Limited Reports Q1 2025 Financial Results
8M ago
Wockhardt’s Zaynich™ Successfully Treats Drug-Resistant Infection in US Pediatric Cancer Patient
Premium
Company Announcements
Wockhardt’s Zaynich™ Successfully Treats Drug-Resistant Infection in US Pediatric Cancer Patient
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100